We’re transforming behavioral health treatment with Drug-Assisted Therapies

Beckley Clinical

A leader in behavioral health innovation

Beckley Clinical is a leader in behavioral health innovation, committed to delivering transformative outcomes through evidence-based drug-assisted therapies (DAT).

Rooted in over 30 years of experience in psychedelic research, Beckley Clinical was founded to address the critical need for effective, accessible, and safe treatments for behavioral health conditions. 

We combine cutting-edge pharmacologic interventions with comprehensive wraparound care to maximize outcomes. Our approach integrates medication, psychotherapy, and lifestyle  supports and interventions for lasting remission and improved quality of life.

Treatment

We currently specialize in Ketamine-Assisted Therapy (KAT) with plans to include psilocybin and MDMA. 

Our hybrid approach allows patients to benefit from a safe in-clinic dosing experience in their community and access to psychological and lifestyle supports from the comfort of their own home. 

Depression disorders

Anxiety disorders

PTSD and trauma-related disorders

Existential distress

and more

How we do it

Hybrid Care Model

In-clinic dosing to maximize safety combined with telehealth-enabled preparation, integration, and support.

Comprehensive
Wraparound Care

Preparation and psychoeducation, integration, psychotherapy, lifestyle intervention and coaching, and continuous monitoring.

Tech-Enabled Solutions

Automated scheduling, symptom tracking, secure telehealth chats, and patient education via our mobile app.

Why it works

The Beckley Clinical approach is evidence-based, and designed to enable a path to remission for most patients with anxiety, depression, and PTSD through the combination and personalization of pharmacy and talk therapy working as a combination therapy. 

Our wraparound services, comprised of integration psychotherapy and lifestyle interventions, prepares the patient for their pharmaco-therapy and takes advantage of  neuroplasticity windows that  enable patients to begin their pathway to remission. 

Pharmaco-Psychoplastogens improve neuroplasticity in the brain and allow the effects of psychotherapy alongside pharmacy interventions to have longer lasting and durable effects. This enables patients to have more symptom-free days and feel like themselves again.

Providers

Learn how to become a clinic in the Beckley Clinical Network →

Health Plans

Learn more about Beckley Clinical solutions and expand access to safe and effective treatment to your members →

Investors

Get in touch with our Investor Relations team today →

Our Evidence Base

Scroll to Top